Oral Ketamine for Treatment Resistant Major Depression - A Double Blind Randomized Controlled Trial

被引：0

作者：

Sharon, Haggai ^{[1
]}

机构：

[1] Tel Aviv Sourasky Med Ctr, Ctr Brain Funct, Tel Aviv, Israel

来源：

BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期

关键词：

Ketamine; Depression;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

340

引用

页码：133S / 134S

页数：2

共 50 条

[21] Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
Jafarinia, Morteza
Afarideh, Mohsen
Tafakhori, Abbas
Arbabi, Mohammad
Ghajar, Alireza
Noorbala, Ahmad Ali
Saravi, Maryam Alamdar
Agah, Elmira
Akhondzadeh, Shahin
[J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 204 : 1 - 8
[22] A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Lapidus, Kyle A. B.
Levitch, Cara F.
Perez, Andrew M.
Brallier, Jess W.
Parides, Michael K.
Soleimani, Laili
Feder, Adriana
Iosifescu, Dan V.
Charney, Dennis S.
Murrough, James W.
[J]. BIOLOGICAL PSYCHIATRY, 2014, 76 (12) : 970 - 976
[23] Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
Cigognini, Marco Aurelio
Guirado, Alia Garrudo
van de Meene, Denise
Schneider, Monica Andreia
Salomon, Monica Sarah
de Alexandria, Vinicius Santana
Adriano, Juliana Pisseta
Thaler, Ana Maria
Fernandes, Fernando dos Santos
Carneiro, Adriana
Moreno, Ricardo Alberto
[J]. FRONTIERS IN PSYCHIATRY, 2022, 13
[24] High-dose Versus Low-dose Oral Ketamine on Control and Relapse of Treatment-resistant Depression: A Randomized, Double-blinded Clinical Trial
KheirAbadi, Gholamreza
Golkar, Shirin
[J]. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (04)
[25] Ketamine and Atropine for Pediatric Sedation A Prospective Double-Blind Randomized Controlled Trial
Asadi, Payman
Ghafouri, Hamed-Basir
Yasinzadeh, Mohammadreza
Kasnavieh, Seid Mohamad Hosseini
Modirian, Ehsan
[J]. PEDIATRIC EMERGENCY CARE, 2013, 29 (02) : 136 - 139
[26] A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose Frequency Study of Intravenous Ketamine in Patients with Treatment-Resistant Depression
Singh, Jaskaran
Fedgchin, Maggie
Daly, Ella
De Boer, Peter
Cooper, Kimberly
Lim, Pilar
Pinter, Christine
Murrough, James
Sanacora, Gerard
Shelton, Richard
Kurian, Benji
Winokur, Andrew
Fava, Maurizio
Manji, Husseini
Drevets, Wayne
Van Nueten, Luc
[J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 44S - 44S
[27] Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: A double-blind randomized trial
Ahmed, Gellan K.
Elserogy, Yasser M.
Elfadl, Ghada Mohammad Abo
Abdelsalam, K. Ghada
Ali, Mostafa A.
[J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 325 : 127 - 134
[28] Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study
Glue, Paul
Neehoff, Shona
Ben Beaglehole
Shadli, Shabah
Mcnaughton, Neil
Hughes-Medlicott, Natalie J.
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (02) : 162 - 167
[29] MOCLOBEMIDE AND PLACEBO IN MILD MAJOR DEPRESSION - A DOUBLE-BLIND RANDOMIZED TRIAL
OSE, E
HOLM, P
[J]. PSYCHOPHARMACOLOGY, 1992, 106 : S114 - S115
[30] Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Muhammad Ishrat Husain
Clare Cullen
Madeha Umer
Andre F. Carvalho
Stefan Kloiber
Jeffrey H. Meyer
Abigail Ortiz
Yuliya Knyahnytska
M. Omair Husain
Justine Giddens
Breno S. Diniz
Wei Wang
Allan H. Young
Benoit H. Mulsant
Zafiris J. Daskalakis
[J]. BMC Psychiatry, 20

← 1 2 3 4 5 →